MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi	https://doi.org/10.1371/journal.pone.0208777	2018	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Role of SNHG7-miR-653-5p-STAT2 feedback loop in regulating neuroblastoma progression	https://doi.org/10.1002/jcp.28017	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases	https://doi.org/10.1080/15384047.2018.1550568	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Exosomal hsa-miR199a-3p Promotes Proliferation and Migration in Neuroblastoma	https://doi.org/10.3389/fonc.2019.00459	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Silencing CASC11 curbs neonatal neuroblastoma progression through modulating microRNA-676-3p/nucleolar protein 4 like (NOL4L) axis	https://doi.org/10.1038/s41390-019-0625-z	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-373 promotes neuroblastoma cell proliferation, migration, and invasion by targeting SRCIN1	https://doi.org/10.2147/OTT.S205582	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
LncRNA SNHG1 contributes to tumorigenesis and mechanism by targeting miR-338-3p to regulate PLK4 in human neuroblastoma	https://doi.org/10.26355/eurrev_201910_19296	2019	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-15a-5p, miR-15b-5p, and miR-16-5p inhibit tumor progression by directly targeting MYCN in neuroblastoma	https://doi.org/10.1002/1878-0261.12588	2019	Cell line 9 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
SLC34A2 promotes neuroblastoma cell stemness via enhancement of miR-25/Gsk3?-mediated activation of Wnt/?-catenin signaling	https://doi.org/10.1002/2211-5463.12594	2019	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest	https://doi.org/10.1080/15476286.2015.1023495	2015	Cell line 4 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Identification of linc-NeD125, a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells	https://doi.org/10.1080/15476286.2015.1096488	2015	Cell line 0 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Suppression of miR-19b enhanced the cytotoxic effects of mTOR inhibitors in human neuroblastoma cells	https://doi.org/10.1016/j.jpedsurg.2016.07.003	2016	Cell line 1 Master/Detail View	Cell line and drug 2 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma	https://doi.org/10.18632/oncotarget.13090	2016	Cell line 8 Master/Detail View	Cell line and drug 8 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State	https://doi.org/10.1158/1541-7786.MCR-19-0187	2019	Cell line 3 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma	https://doi.org/10.1177/1176935119832910	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-?1 induced LMO1 via control of let-7 expression	https://doi.org/10.1016/j.brainres.2018.10.015	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression	https://doi.org/10.1038/aps.2015.153	2016	Cell line 2 Master/Detail View	Cell line and drug 1 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor	https://doi.org/10.7314/apjcp.2015.16.11.4509	2015	Cell line 2 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View
miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3? and SFRP1	https://doi.org/10.1016/j.biopha.2016.07.010	2016	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity	https://doi.org/10.3892/mmr.2017.6187	2017	Cell line 1 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 0 Master/Detail View

Publications